Form 4: Bausch Health Director John Paulson Receives Restricted Share Units

Director John Paulson received 35,360 restricted share units from Bausch Health Companies Inc. on May 17, 2024.

Summary

• John Paulson, a director of Bausch Health Companies Inc., received 35,360 restricted share units on May 17, 2024.
• These RSUs were granted as compensation for non-employee directors following their election at the Issuer's Annual Meeting of Shareholders.
• The RSUs have a grant date value of $250,000.
• The RSUs vest immediately prior to the Issuer's next Annual Meeting of Shareholders and will be settled in common shares of Bausch Health.
• Following the transaction, Paulson beneficially owns 243,669 common shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (granting of RSUs to a director), which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative sentiment.

Positives

• The grant of RSUs aligns the interests of the non-employee directors with those of the shareholders.
• The immediate vesting before the next annual meeting ensures continued engagement and oversight by the director.

Future Outlook

The RSUs will vest immediately prior to the next Annual Meeting of Shareholders and will be settled in common shares of Bausch Health.

Industry Context

Granting RSUs to directors is a common practice to align their interests with shareholders and incentivize long-term value creation. This is a standard compensation practice in publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• The value of the RSU grant ($250,000) appears to be within a typical range for non-executive director compensation at companies of similar size and complexity to Bausch Health.
• Comparing Bausch Health's director compensation to peers like Teva Pharmaceutical Industries or Mylan (now Viatris) would provide a more detailed benchmark.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns director interests with long-term company performance.
• The grant of RSUs does not have a direct impact on employees, customers, suppliers, or creditors.

Next Steps

• The RSUs will vest immediately prior to the next Annual Meeting of Shareholders.
• The RSUs will be settled in common shares of Bausch Health.

Key Dates